Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Covington
Deloitte
McKinsey
Federal Trade Commission
Baxter
Healthtrust
UBS
Chinese Patent Office

Generated: April 27, 2018

DrugPatentWatch Database Preview

PHENOXYBENZAMINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Phenoxybenzamine Hydrochloride, and what generic alternatives are available?

Phenoxybenzamine Hydrochloride is a drug marketed by Par Pharm Inc and West-ward Pharms Int and is included in two NDAs.

The generic ingredient in PHENOXYBENZAMINE HYDROCHLORIDE is phenoxybenzamine hydrochloride. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the phenoxybenzamine hydrochloride profile page.
Drug patent expirations by year for PHENOXYBENZAMINE HYDROCHLORIDE
Pharmacology for PHENOXYBENZAMINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for PHENOXYBENZAMINE HYDROCHLORIDE
Synonyms for PHENOXYBENZAMINE HYDROCHLORIDE
055P152
2-(N-Benzyl-2-chloroethylamino)-1-phenoxypropane hydrochloride
63-92-3
AB0013102
AB2000604
AC-8077
AC1NR4GD
AC1Q396G
AI3-52044
AK-64371
AKOS015966790
AN-8367
ANW-45430
AOB5790
AS-16927
B-019
Bensylyt NEN
Bensylyte HCl
Benzene methanamine
Benzenemethanamine, N-(2-chloroethyl)-N-(1-methyl-2-phenoxyethyl)-, hydrochloride
Benzyl(2-chloroethyl)(1-methyl-2-phenoxyethyl)amine hydrochloride
benzyl(2-chloroethyl)(1-phenoxypropan-2-yl)amine hydrochloride
Benzylamine, N-(2-chloroethyl)-N-(1-methyl-2-phenoxyethyl)-, hydrochloride
C07436
C18H23Cl2NO
CAS-63-92-3
CCG-39614
CCRIS 506
CHEBI:8078
CHEMBL1200787
CPD000058422
CS-2537
CTK6H8164
D00507
D0158
Dibenzyline
Dibenzyline (TN)
Dibenzyline chloride
Dibenzyline hyd rochloride
Dibenzyline hydrochloride
DSSTox_CID_1127
DSSTox_GSID_21127
DSSTox_RID_75958
DTXSID0021127
EINECS 200-569-7
EN300-52514
EU-0100235
fenoxybenzamin
FT-0603264
H533
HMS1570N10
HY-B0431A
HYDROGEN PHENOXYBENZAMINE CHLORIDE
J-009731
LP00235
LS-1516
MCULE-2455465785
MFCD00055152
MLS000069374
MLS002222313
MolPort-003-666-770
N-(2-Chloroethyl)-N-(1-methyl-2-phenoxyethyl)-benzylamine Hydrochloride
N-(2-Chloroethyl)-N-(1-methyl-2-phenoxyethyl)benzenemethanamine hydrochloride
N-(2-Chloroethyl)-N-(1-methyl-2-phenoxyethyl)benzylamine hydrochloride
N-(2-Chloroethyl)-N-(1-methyl-2-phenoxyethyl)benzylamine, hydrochloride
N-2-phenoxyisopropyl- N-benzyl-chloroethylamine hydrochloride
N-2-Phenoxyisopropyl-N-benzyl-beta-chloroethylamine hydrochloride
N-2-Phenoxyisopropyl-N-benzyl-chloroethylamine hydrochloride
N-benzyl-N-(2-chloroethyl)-1-phenoxy-propan-2-amine hydrochloride
N-benzyl-N-(2-chloroethyl)-1-phenoxypropan-2-amine hydrochloride
N-benzyl-N-(2-chloroethyl)-1-phenoxypropan-2-amine;hydrochloride
N-Benzyl-N-phenoxyisopropyl-beta-chlorethylamine hydrochloride
N-Phenoxyisopropyl-N-benzyl-2-chloroethylamine Hydrochloride
N-Phenoxyisopropyl-N-benzyl-beta-chloroethylamine hydrochloride
NC00598
NCGC00089748-02
NCGC00089748-06
NCGC00093699-01
NCGC00093699-02
NCGC00093699-03
NCGC00093699-04
NCGC00256370-01
NCGC00259137-01
NCI-C01661
NE47907
NSC-37448
NSC-759572
NSC37448
NSC759572
Opera_ID_300
OR068787
OR157675
Pharmakon1600-02300176
phenoxybenzamide hydrochloride
Phenoxybenzamine (hydrochloride)
Phenoxybenzamine chloride
Phenoxybenzamine Hcl
Phenoxybenzamine hydrochloride (USP)
Phenoxybenzamine hydrochloride [USAN]
Phenoxybenzamine hydrochloride, >=97%, powder
Phenoxybenzamine Hydrochloride, pharmaceutical secondary standard; traceable to USP
Phenoxybenzamine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Phenoxybenzamine.HCl
Phenyoxybenzamine hydrochloride
RT-000645
S2499
SAM002548984
SAM002564244
SCHEMBL50729
SMR000058422
SPECTRUM2300176
SR-01000000017
SR-01000000017-2
ST2407428
Tox21_201588
Tox21_302978
WLN: G2N1R&Y1&1OR &GH

US Patents and Regulatory Information for PHENOXYBENZAMINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm Inc PHENOXYBENZAMINE HYDROCHLORIDE phenoxybenzamine hydrochloride CAPSULE;ORAL 204522-001 Jan 24, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
West-ward Pharms Int PHENOXYBENZAMINE HYDROCHLORIDE phenoxybenzamine hydrochloride CAPSULE;ORAL 201050-001 Jul 16, 2012 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Deloitte
Cipla
Merck
Julphar
Johnson and Johnson
UBS
Citi
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.